Report Code: 12141 | Available Format: PDF | Pages: 210
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Technology
1.3.2 Market Segmentation by Application
1.3.3 Market Segmentation by Demography
1.3.4 Market Segmentation by Region
1.3.5 Analysis Period
1.3.6 Market Data Reporting Unit
1.4 Key Stakeholders
Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown of Primary Research Respondents
2.2.1.1 By region
2.2.1.2 By industry participant
2.2.1.3 By company type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Currency Conversion Rates
2.6 Assumptions for the Study
2.7 Notes & Caveats
Chapter 3. Executive Summary
Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Technology
4.1.1.1 Radiofrequency (RF) microneedling
4.1.1.2 Dermal fillers
4.1.1.3 Laser skin resurfacing
4.1.1.4 Mesotherapy
4.1.2 By Application
4.1.2.1 Wrinkles
4.1.2.2 Aging
4.1.2.3 Acne and other scars
4.1.2.4 Hyperpigmentation
4.1.2.5 Others
4.1.3 By Demography
4.1.3.1 Baby boomers
4.1.3.2 Generation X
4.1.3.3 Generation Y
4.1.3.4 Generation Z
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Rising inclination toward improved appearance
4.2.2 Drivers
4.2.2.1 Increasing awareness through seminars and conferences
4.2.2.2 Surging geriatric population
4.2.2.3 Rising disposable income
4.2.2.4 Growing medical tourism industry
4.2.2.5 Increasing volume of anti-aging cosmetic procedures
4.2.2.6 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 Stringent regulatory requirements
4.2.3.2 Risks and side-effects associated with facial skin ablative treatment products
4.2.3.3 Impact analysis of restraints on market forecast
4.2.4 Opportunities
4.2.4.1 Unmet need for minimally or non-invasive treatments
4.2.4.1 Extensive research leading to technical innovations
4.3 Impact of COVID-19
4.4 Porter’s Five Forces Analysis
Chapter 5. Global Market Size and Forecast
5.1 By Technology
5.2 By Application
5.3 By Demography
5.4 By Region
Chapter 6. North America Market Size and Forecast
6.1 By Technology
6.2 By Application
6.3 By Demography
6.4 By Country
6.4.1 U.S. Facial Skin Ablative Treatment Market
6.4.1.1 By technology
6.4.1.2 By application
6.4.1.3 By demography
6.4.2 Canada Facial Skin Ablative Treatment Market
6.4.2.1 By technology
6.4.2.2 By application
6.4.2.3 By demography
Chapter 7. Europe Market Size and Forecast
7.1 By Technology
7.2 By Application
7.3 By Demography
7.4 By Country
7.4.1 Germany Facial Skin Ablative Treatment Market
7.4.1.1 By technology
7.4.1.2 By application
7.4.1.3 By demography
7.4.2 France Facial Skin Ablative Treatment Market
7.4.2.1 By technology
7.4.2.2 By application
7.4.2.3 By demography
7.4.3 U.K. Facial Skin Ablative Treatment Market
7.4.3.1 By technology
7.4.3.2 By application
7.4.3.3 By demography
7.4.4 Italy Facial Skin Ablative Treatment Market
7.4.4.1 By technology
7.4.4.2 By application
7.4.4.3 By demography
7.4.5 Spain Facial Skin Ablative Treatment Market
7.4.5.1 By technology
7.4.5.2 By application
7.4.5.3 By demography
Chapter 8. APAC Market Size and Forecast
8.1 By Technology
8.2 By Application
8.3 By Demography
8.4 By Country
8.4.1 China Facial skin ablative treatment market
8.4.1.1 By technology
8.4.1.2 By application
8.4.1.3 By demography
8.4.2 Japan Facial Skin Ablative Treatment Market
8.4.2.1 By technology
8.4.2.2 By application
8.4.2.3 By demography
8.4.3 India Facial Skin Ablative Treatment Market
8.4.3.1 By technology
8.4.3.2 By application
8.4.3.3 By demography
8.4.4 Australia Facial Skin Ablative Treatment Market
8.4.4.1 By technology
8.4.4.2 By application
8.4.4.3 By demography
Chapter 9. LATAM Market Size and Forecast
9.1 By Technology
9.2 By Application
9.3 By Demography
9.4 By Country
9.4.1 Brazil Facial Skin Ablative Treatment Market
9.4.1.1 By technology
9.4.1.2 By application
9.4.1.3 By demography
Chapter 10. MEA Market Size and Forecast
10.1 By Technology
10.2 By Application
10.3 By Demography
10.4 By Country
10.4.1 Saudi Arabia Facial Skin Ablative Treatment Market
10.4.1.1 By technology
10.4.1.2 By application
10.4.1.3 By demography
Chapter 11. Competitive Landscape
11.1 Strategic Developments of Key Players
11.1.1 Product Launches
11.1.2 Mergers and Acquisitions
11.1.3 Others
11.2 Major Players and Their Offering
Chapter 12. Company Profiles
12.1 Alma Lasers Ltd.
12.1.1 Business Overview
12.1.2 Product and Service Offerings
12.2 Lumenis Ltd.
12.2.1 Business Overview
12.2.2 Product and Service Offerings
12.3 Syneron Medical Ltd.
12.3.1 Business Overview
12.3.2 Product and Service Offerings
12.4 Cutera Inc.
12.4.1 Business Overview
12.4.2 Product and Service Offerings
12.4.3 Key Financial Summary
12.5 Sciton Inc.
12.5.1 Business Overview
12.5.2 Product and Service Offerings
12.6 EL.EN. S.p.A.
12.6.1 Business Overview
12.6.2 Product and Service Offerings
12.6.3 Key Financial Summary
12.7 Laseroptek Co. Ltd.
12.7.1 Business Overview
12.7.2 Product and Service Offerings
12.8 Fotona D.o.o.
12.8.1 Business Overview
12.8.2 Product and Service Offerings
12.9 Imdad LLC
12.9.1 Business Overview
12.9.2 Product and Service Offerings
12.10 Hologic Inc.
12.10.1 Business Overview
12.10.2 Product and Service Offerings
12.10.3 Key Financial Summary
12.11 Stryker Corporation
12.11.1 Business Overview
12.11.2 Product and Service Offerings
12.11.3 Key Financial Summary
12.12 Crown Laboratories Inc.
12.12.1 Business Overview
12.12.2 Product and Service Offerings
12.13 Delasco LLC
12.13.1 Business Overview
12.13.2 Product and Service Offerings
12.14 Lutronic Corp.
12.14.1 Business Overview
12.14.2 Product and Service Offerings
12.15 INSTITUTE BCN ESTHETICS SL
12.15.1 Business Overview
12.15.2 Product and Service Offerings
12.16 Koru Pharmaceuticals Co. Ltd.
12.16.1 Business Overview
12.16.2 Product and Service Offerings
12.17 CAREGEN Co. LTD.
12.17.1 Business Overview
12.17.2 Product and Service Offerings
12.18 HUGEL Inc.
12.18.1 Business Overview
12.18.2 Product and Service Offerings
12.19 Allergan plc
12.19.1 Business Overview
12.19.2 Product and Service Offerings
12.19.3 Key Financial Summary
12.20 Galderma SA
12.20.1 Business Overview
12.20.2 Product and Service Offerings
12.21 Merz Pharma GmbH & Co. KGaA
12.21.1 Business Overview
12.21.2 Product and Service Offerings
12.21.3 Key Financial Summary
12.22 Shenb Co. Ltd.
12.22.1 Business Overview
12.22.2 Products & Services
Chapter 13. Appendix
13.1 Abbreviations
13.2 Sources and References
13.3 Related Reports
LIST OF TABLES
TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 GDP PER CAPITA, BASED ON PURCHASING POWER PARITY (PPP), USD (2015–2018)
TABLE 3 COSMETIC PROCEDURES PERFORMED WORLDWIDE IN 2018
TABLE 4 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 5 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 6 MINIMALLY AND NON-INVASIVE ANTI-AGING TREATMENTS
TABLE 7 GLOBAL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2019–2024)
TABLE 8 GLOBAL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2025–2030)
TABLE 9 GLOBAL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2019–2024)
TABLE 10 GLOBAL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2025–2030)
TABLE 11 GLOBAL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2019–2024)
TABLE 12 GLOBAL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2025–2030)
TABLE 13 GLOBAL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY REGION, $M (2019–2024)
TABLE 14 GLOBAL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY REGION, $M (2025–2030)
TABLE 15 NORTH AMERICA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2019–2024)
TABLE 16 NORTH AMERICA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2025–2030)
TABLE 17 NORTH AMERICA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2019–2024)
TABLE 18 NORTH AMERICA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2025–2030)
TABLE 19 NORTH AMERICA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2019–2024)
TABLE 20 NORTH AMERICA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2025–2030)
TABLE 21 NORTH AMERICA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY COUNTRY, $M (2019–2024)
TABLE 22 NORTH AMERICA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY COUNTRY, $M (2025–2030)
TABLE 23 U.S. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2019–2024)
TABLE 24 U.S. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2025–2030)
TABLE 25 U.S. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2019–2024)
TABLE 26 U.S. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2025–2030)
TABLE 27 U.S. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2019–2024)
TABLE 28 U.S. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2025–2030)
TABLE 29 CANADA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2019–2024)
TABLE 30 CANADA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2025–2030)
TABLE 31 CANADA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2019–2024)
TABLE 32 CANADA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2025–2030)
TABLE 33 CANADA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2019–2024)
TABLE 34 CANADA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2025–2030)
TABLE 35 EUROPE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2019–2024)
TABLE 36 EUROPE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2025–2030)
TABLE 37 EUROPE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2019–2024)
TABLE 38 EUROPE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2025–2030)
TABLE 39 EUROPE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2019–2024)
TABLE 40 EUROPE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2025–2030)
TABLE 41 EUROPE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY COUNTRY, $M (2019–2024)
TABLE 42 EUROPE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY COUNTRY, $M (2025–2030)
TABLE 43 GERMANY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2019–2024)
TABLE 44 GERMANY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2025–2030)
TABLE 45 GERMANY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2019–2024)
TABLE 46 GERMANY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2025–2030)
TABLE 47 GERMANY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2019–2024)
TABLE 48 GERMANY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2025–2030)
TABLE 49 FRANCE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2019–2024)
TABLE 50 FRANCE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2025–2030)
TABLE 51 FRANCE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2019–2024)
TABLE 52 FRANCE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2025–2030)
TABLE 53 FRANCE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2019–2024)
TABLE 54 FRANCE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2025–2030)
TABLE 55 U.K. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2019–2024)
TABLE 56 U.K. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2025–2030)
TABLE 57 U.K. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2019–2024)
TABLE 58 U.K. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2025–2030)
TABLE 59 U.K. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2019–2024)
TABLE 60 U.K. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2025–2030)
TABLE 61 SURGICAL AND NON-SURGICAL COSMETIC PROCEDURES PERFORMED IN ITALY (2023)
TABLE 62 ITALY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2019–2024)
TABLE 63 ITALY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2025–2030)
TABLE 64 ITALY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2019–2024)
TABLE 65 ITALY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2025–2030)
TABLE 66 ITALY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2019–2024)
TABLE 67 ITALY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2025–2030)
TABLE 68 SPAIN FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2019–2024)
TABLE 69 SPAIN FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2025–2030)
TABLE 70 SPAIN FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2019–2024)
Get a bespoke market intelligence solution
Want a report tailored exactly to your business strategy?
Request CustomizationWant an insight-rich discussion with the report author?
Speak to AnalystOur dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws